Greener Pastures? Long-Time Pfizer China GM Starts New Era
Executive Summary
15 year-serving Pfizer China GM Wu Xiaobing and AstraZeneca China's Senior VP for biologics Shoubai Chao are the latest to jump on board China's booming biotech boat, are there more to come?
You may also be interested in...
Asia Executives To Watch: Moves At ZAI, Daiichi Sankyo And Others
The coming of June has brought new executives at Daiichi Sankyo, UCB, ViiV in Japan and ZAI Lab in China.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Chinese Language Podcast: BIOSECURE Act, US PD-1 Approval, ADC Updates
Guest speaker and lawyer Kevin Duan joins Brian Yang and Dexter Yan to discuss the planned US BIOSECURE Act, the US approval of BeiGene's anti-PD-1 drug and the latest antibody-drug conjugates in development at Chinese pharma firms.